M
Maze Therapeutics, Inc. (MAZE)
NGM – Real Time Price. Currency in USD
28.43
+1.41 (5.22%)
At close: Jun 26, 2026, 4:00 PM EDT
28.99
+0.56 (1.97%)
After-hours: Jun 26, 2026, 6:16 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
28.43
+1.41 (5.22%)
At close: Jun 26, 2026, 4:00 PM EDT
28.99
+0.56 (1.97%)
After-hours: Jun 26, 2026, 6:16 PM EDT
| Breakdown | |
|---|---|
| 1.46% | % of Shares Held by All Insider |
| 95.47% | % of Shares Held by Institutions |
| 96.88% | % of Float Held by Institutions |
| 218 | Number of Institutions Holding Shares |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 4.57M | 2026-03-31 | 8.25% | $117.29M |
| TRV GP IV, LLC | 4.47M | 2026-03-31 | 8.08% | $114.89M |
| Arch Venture Management, Llc | 4.12M | 2026-03-31 | 7.44% | $105.80M |
| Deep Track Capital, Lp | 3.48M | 2026-03-31 | 6.28% | $89.30M |
| Janus Henderson Group PLC | 2.86M | 2026-03-31 | 5.17% | $73.42M |
| Paradigm Biocapital Advisors LP | 2.74M | 2026-03-31 | 4.96% | $70.48M |
| Blackrock Inc. | 2.57M | 2026-03-31 | 4.64% | $66.01M |
| a16z Capital Management, L.L.C. | 1.70M | 2026-03-31 | 3.08% | $43.71M |
| Venrock Adviser, LLC | 1.60M | 2026-03-31 | 2.89% | $41.14M |
| Vanguard Capital Management LLC | 1.44M | 2026-03-31 | 2.59% | $36.87M |
| Alphabet Inc. | 1.39M | 2026-03-31 | 2.51% | $35.49M |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.16M | 2026-03-31 | 2.10% | $29.85M |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 739,660 | 2026-04-30 | 1.34% | $18.99M |
| iShares Trust-iShares Russell 2000 ETF | 619,132 | 2026-04-30 | 1.12% | $15.90M |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 324,041 | 2025-12-31 | 0.59% | $7.64M |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 234,961 | 2026-03-31 | 0.42% | $6.03M |
| iShares Trust-iShares Biotechnology ETF | 231,581 | 2026-04-30 | 0.42% | $5.95M |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 209,909 | 2026-02-28 | 0.38% | $5.39M |
| iShares Trust-iShares Russell 2000 Value ETF | 208,744 | 2026-04-30 | 0.38% | $5.36M |
| BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio | 184,453 | 2026-02-28 | 0.33% | $4.74M |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 128,000 | 2026-02-28 | 0.26% | $3.45M |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 126,746 | 2026-05-31 | 0.23% | $3.25M |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 111,948 | 2026-04-30 | 0.20% | $2.87M |